BioSpace News Archive

The quantitative next-generation sequencing blood test for infectious diseases makes an international impact

Superior quality ultrapure and pure water in an ergonomic and compact design, to improve productivity, reduce waste and accelerate research

The Ministry of Health and Prevention (MOHAP) has announced the second phase completion of its initiative, ‘Heart Experts,’ which designates a select group of students to serve as awareness ambassadors for cardiovascular health in their schools, neighborhood and local community.

Al Qassimi, Khorfakkan, Saqr, Shaam, Fujairah, Dibba, Kuwait, Obaidullah and Kalba hospitals covered under the program

Oxurion NV announced today the appointment of Adrienne Graves, Ph.D., to its board of directors. Dr. Graves will replace Paul Howes, who has been a board member since 2014.

Cabaletta Bio launched out of the University of Pennsylvania with an exclusive license deal and two multi-year sponsored research agreements. The fledgling biotech company will work on engineered T cell products for B cell-mediated autoimmune disease.

Months after the U.S. Food and Drug Administration (FDA) rejected Insys Therapeutics’ buprenorphine sublingual spray for moderate-to-severe acute pain, the Arizona-based company is assessing strategic alternatives for its opioid-related assets as it continues to shift its focus to a new therapeutic – cannabinoids.

Hundreds of millions of dollars have been pledged by billionaires to advance scientific research.

BASF AS completed a randomized, placebo-controlled clinical trial in the U.S., newly published in Nutrients, evaluating the use of high concentrate omega-3 to correct the nutritional deficiency of omega-3 fatty acid in patients with non-alcoholic fatty liver disease (NAFLD). Several studies have shown that NAFLD patients have lower levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)i.

Gail Maderis, currently president and chief executive officer of South San Francisco-based Antiva Biosciences, has a rock-solid resume.